2020 GA Meeting May 6th in Kristiansand (KRS), Norway

2019 GA MEETING

The 2019 GA meeting which took place on Wednesday 8 May 2019 in Madrid, Spain was a resounding success. Hosted by FerroGlobe, the meeting which lasted 4 hours saw several deliberations related to the consortium governace, dossier updates and classification & labelling. Some key decisions taken by way of vote are as follows:

Some highlights:

  • Executive Committee: A new Chairmanand  a new 2nd Vice Chairman were appointed, meanwhile the 1st Vice Chiarman was maintained to enure continuity 
  • Dossier updates: Reveal changes in classification and labelling if compared to the 2010 submitted dossiers
  • Approval of the 2018 workplan and budget
  • Brexit and data: Mara will continue to support REACH registration inside and outside the EU (UK REACH inclusive) but at a charge yet to be determined 

13-Week Inhalation Toxicity Study in the Wistar Rat /Mn metal/OECD 413/GLP/

In this 13 - week inhalation toxicity study Mn Metal Powder was administered 6 hours daily for 5 days/week to rats by nose-only, flow-past inhalation exposure. The reversibility or progression of any test item related effects or any delayed toxicity was assessed during a 4 - week treatment free recovery period following the treatment period. The study comprised four groups containing 25 male and 25 female rats in group 1 and 31 male and 31 female rats in groups 2 to 4. The rats of the control group (group 1) were exposed to air only. Groups 2 to 4 were exposed to target concentrations of 0.5, 5 and 20 µg/L Mn Metal Powder, respectively.

Throughout the study all animals were observed for viability and clinical signs. In addition body weights and food consumption were recorded. Detailed clinical signs and functional observation battery were performed. Ophthalmoscopic examinations were performed and blood and urine samples were taken for clinical laboratory investigations. Blood, brain and lungs were taken for measurements of Mn levels in different blood compartments as well as brain areas. Following completion of the treatment and recovery period, a detailed necropsy was performed on all animals and

Conclusion

In accordance to the findings above the lung was considered to be the target organ for the exposure to Mn Metal Powder mainly because it was the port of entry. There was indication of reversibility of the findings, however, the 4 week duration of the recovery period was considered insufficient to demonstrate full reversal of all findings.

Based on the histopathological findings in this study a No-Observed-Adverse-Effect-Level (NOAEL) was established at 0.5 µg/L Mn Metal Powder.

selected organs were weighed. Various tissues and organs were placed in fixative, processed and examined microscopically. Neuropathology was performed in selected animals.

 

« Back to studies


About cookies on our website

Following a revised EU directive on website cookies, each company based, or doing business, in the EU is required to notify users about the cookies used on their website.

Our site uses cookies to improve your experience of certain areas of the site and to allow the use of specific functionality like social media page sharing. You may delete and block all cookies from this site, but as a result parts of the site may not work as intended.

To find out more about what cookies are, which cookies we use on this website and how to delete and block cookies, please see our Which cookies we use page.

Click on the button below to accept the use of cookies on this website (this will prevent the dialogue box from appearing on future visits)